Upvote
Downvote
Oncology Territory Manager, Northcentral
Share Job
- Suggest Revision
$150
- Enabled by our proprietary drug discovery platform, Deciphera has developed a diverse pipeline of wholly-owned drug candidates.
- QINLOCK (ripretinib) is Deciphera’s switch control inhibitor developed for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Switzerland, Taiwan, the United States, and the United Kingdom.
- Success in this role will require:Partnering with cross-functional commercial partners such as market access and medical teams to provide comprehensive solutions for customers.
- Becoming a true subject matter expert on all key topics that impact the success of the business – GIST and TGCT disease state knowledge, clinical acumen, product expertise, competitive intelligence, market dynamics, customer needs across segments, local market access, etc.
- in partnership with field partners Utilizing CRM as a strategic tool for assessing and tracking customer status and progressing sales plans Completing sales administrative requirements (T&E, compliance SOPs, Sunshine reporting, etc.)
Active Job
Updated TodaySimilar Job
Relevance
Active